ARDELYX INC. - COMMON STOCK

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

17 يوليو 2024 14:10:43 بحسب Nasdaq GlobeNewswire

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

02 يوليو 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

28 يونيو 2024 05:17:59 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 مايو 2024 13:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

22 مايو 2024 05:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

21 مايو 2024 05:02:21 بحسب Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

16 مايو 2024 05:01:41 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

14 مايو 2024 13:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

07 مايو 2024 05:01:45 بحسب Nasdaq GlobeNewswire

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

02 مايو 2024 13:02:28 بحسب Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

01 مايو 2024 05:00:01 بحسب Nasdaq GlobeNewswire

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

18 أبريل 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

28 مارس 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

25 مارس 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

12 مارس 2024 13:35:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

27 فبراير 2024 05:00:22 بحسب Nasdaq GlobeNewswire

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

22 فبراير 2024 13:01:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

01 فبراير 2024 05:00:08 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

12 يناير 2024 04:56:28 بحسب Nasdaq GlobeNewswire

Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities

08 يناير 2024 05:00:00 بحسب Nasdaq GlobeNewswire